Question 1

Who is Kathryn Romano?

Accepted Answer

Kathryn Romano serves as Executive at Krystal Biotech, Inc. (KRYS). They have executed 22 insider transactions totaling $5.8M over their tenure at the company.

Question 2

What is Kathryn Romano's role at Krystal Biotech, Inc.?

Accepted Answer

Kathryn Romano holds the position of Executive at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.

Question 3

Is Kathryn Romano buying or selling KRYS stock?

Accepted Answer

Kathryn Romano has shown a selling trading pattern, with $0 in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Kathryn Romano's largest insider transactions?

Accepted Answer

The largest transaction by Kathryn Romano was on May 22, 2023, when they sold $1.4M worth of KRYS shares. This transaction involved 12,500 shares at $110.00 per share.

Question 5

What is Kathryn Romano's trading accuracy?

Accepted Answer

Kathryn Romano has a Personal Accuracy Score of 95/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Kathryn Romano associated with?

Accepted Answer

Kathryn Romano has filed Form 4 transactions for 1 different company. Their primary association is with Krystal Biotech, Inc. (KRYS), where they serve as Executive.

Question 7

How much KRYS stock does Kathryn Romano own?

Accepted Answer

Kathryn Romano currently owns 12,556 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Kathryn Romano's equity in Krystal Biotech, Inc.?

Accepted Answer

Kathryn Romano's equity position in Krystal Biotech, Inc. consists of 12,556 shares valued at approximately $0. As Executive, they have executed 22 insider transactions, with $0 in purchases and $5.8M in sales.

Question 9

Where can I find Kathryn Romano's SEC Form 4 filings?

Accepted Answer

All of Kathryn Romano's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathryn Romano has 22 Form 4 filings on record as an insider at Krystal Biotech, Inc..

Question 10

What is Kathryn Romano's net worth from KRYS?

Accepted Answer

Based on their current KRYS stock holdings, Kathryn Romano has equity worth approximately $0 in Krystal Biotech, Inc.. This value is based on 12,556 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Jan 22, 2024	KRYS	$325.0K	Sale	2,500	$130.00	Planned
Jan 22, 2024	KRYS	$130.7K	Option Exercise	2,500

Kathryn Romano

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Kathryn Romano Trading Summary

How Much KRYS Stock Does Kathryn Romano Own?

Is Kathryn Romano Buying or Selling KRYS?

Kathryn Romano's Recent Stock Transactions

Frequently Asked Questions

Track Kathryn Romano's Trades